The Ralph C. Wilson, Jr. Foundation has announced a milestone $4.2 million donation to Roswell Park Cancer Institute’s quality-of-life programs — marking the Foundation’s first announced gift and kicking off the group’s distribution of its 2015 Transitional Legacy Grant Program.

In separate studies presented at the just-concluded European Cancer Congress (ECCO 2015), which was held in conjunction with the annual meeting of the European Society for Medical Oncology (ESMO 2015), researchers from Roswell Park Cancer Institute (RPCI) reported promising findings about a pair of breakthrough drugs in cancers that have in the past proven to be notoriously difficult to treat.

Three-quarters of women treated for ovarian cancer face relapse of their disease. And while those who respond well to initial therapy do tend to survive longer, they require additional treatment for recurring cancer just as frequently as other women whose initial treatment response was not so pronounced.

Roswell Park Cancer Institute (RPCI) has once again been included on Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, an annual list of centers that are national leaders in patient care, cancer outcomes and research.

Candace S. Johnson, PhD, President & CEO and Wallace Family Chair in Translational Research at Roswell Park Comprehensive Cancer Center, was recognized as the 2015 honoree at the American Cancer Society’s (ACS) Cuisine for a Cure gala, held on Saturday, Sept. 19 at Statler City.

Candace Johnson, PhD, President and CEO of Roswell Park Cancer Institute is elected to the Board of Directors of the Association of American Cancer Institutes, effective at the national organization’s annual meeting to be held in Washington, D.C. on Sunday, October 25.